Regarding the expression levels of CD68 as a M1-TAM marker in carcinomas and prognosis, it has been reported that the low expression of CD68 and CD163 in classical Hodgkin lymphoma indicates a better prognosis [63]. The gene discussed is CD68; the disease is carcinoma.